Skye Bioscience SKYE Cash Flow Statement (2012-2026)

NASDAQ SKYE
$0.28 -0.03 (-9.68%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Dec2013 Apr2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-2.02M-1.82M-2.51M-3.04M-3.42M-3.13M-9.89M-5.17M-3.11M-24.95M-4.42M-5.02M-7.90M-3.90M-9.75M-11.10M-17.62M-12.75M-14.44M-12.51M
Depreciation and Depletion (Quarter)
0.00M0.01M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M-0.05M0.03M0.03M0.07M0.08M
Share-based Compensation (Quarter)
0.11M0.49M0.12M0.14M0.14M0.14M0.20M0.13M0.10M0.16M0.59M2.48M1.83M1.92M2.09M2.20M2.03M1.91M-6.15M1.50M
Gains from Investment Securities (Quarter)
-0.04M-0.01M-0.01M-323.00-3.00
Cash from Operations (Quarter)
-1.67M-1.49M-1.97M-2.91M-2.90M-2.06M-4.87M-4.06M-1.99M-4.05M-3.84M-4.71M-7.09M-5.26M-8.17M-9.19M-10.75M-13.36M-9.77M-8.56M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)
406.00420.000.59M0.15M444.00459.000.49M0.00M0.33M0.24M0.01M0.00M-0.58M0.17M
Depreciation & Amortization (CF) (Quarter)
0.00M0.01M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M-0.05M0.03M0.03M0.07M0.18M0.18M0.19M0.18M0.18M0.17M
Change in Working Capital
Change in Receivables (Quarter)
Change in Account Payables (Quarter)
0.01M-0.07M0.06M0.02M0.08M0.27M-0.26M-0.45M0.43M-0.10M-0.01M-0.06M-0.02M-0.30M-0.21M1.22M1.37M-0.40M-0.79M1.90M
Change in Accured Expenses (Quarter)
0.24M-0.16M-0.07M0.04M0.04M0.04M0.18M-0.13M0.39M-0.83M0.80M0.08M-0.42M1.44M-0.88M0.22M-0.46M2.26M0.29M-1.04M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
-0.01M-0.00M-0.02M-0.02M-0.02M-0.02M0.00M-0.05M-0.01M-0.02M-0.02M-0.02M-0.02M-0.04M-0.04M-0.04M-0.05M-0.05M-0.21M
Investing Activities
Capital Expenditures (Quarter)
-526.000.03M-0.03M0.00M0.00M0.95M-0.92M0.00M-0.00M0.01M0.00M0.03M1.52M-1.51M0.01M-0.01M-0.02M
Sales of Property, Plant and Equipment (Quarter)
5.53M1.15M0.07M850.00
Acquisitions (Quarter)
5.31M
Divestments (Quarter)
1.15M0.07M0.14M0.09M0.09M0.18M
Cash from Investing Activities (Quarter)
526.00-0.03M-0.05M-0.00M-0.08M-0.37M5.67M5.53M1.07M-0.01M1.14M-0.03M-1.45M0.09M-12.81M-11.86M7.97M-2.80M10.90M
Financing Activities
Other financing activities (Quarter)
-0.01M7.00M0.00M-0.00M0.01M-0.01M85.65M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
-4.71M0.07M
Short-Term Debt issuances (Quarter)
0.06M0.09M0.09M0.37M0.05M0.12M0.07M-0.24M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
-6.76M-83.56M
Misc.
Cash from Financing Activities (Quarter)
1.70M7.42M-0.08M-0.06M-0.09M-0.09M0.03M-0.05M-0.12M16.63M-0.02M85.65M-2.10M0.01M0.02M0.01M-0.07M
Change in Cash (Quarter)
0.03M5.90M-2.11M-2.98M-3.08M-2.51M0.83M1.42M-2.12M13.65M-3.87M82.09M-9.22M-6.71M-8.08M-21.99M-22.58M-5.40M-12.56M2.27M
Free Cash Flow (Quarter)
-1.67M-1.52M-1.94M-2.92M-2.90M-3.00M-3.95M-4.06M-1.99M-4.05M-3.86M-4.71M-7.13M-6.78M-6.66M-9.19M-10.75M-13.36M-9.76M-8.54M
Net Cash Flow (Quarter)
0.03M5.90M-2.11M-2.98M-3.08M-2.51M0.83M1.42M-2.12M13.65M-3.87M82.09M-9.22M-6.71M-8.08M-21.99M-22.58M-5.40M-12.56M2.27M